DOCSLIB.ORG

Lab Investigation of Hemolysis Presentation 9-19-18 Ver.1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

9/23/2018 Investigation of Jason Anderson, Hemolysis in the MPH, MT(ASCP) Field Product Clinical Specialist Laboratory Objectives 1. Define hemolysis. 2. Distinguish between intrinsic and extrinsic hemolysis 3. Explain where in the body hemolysis can take place. 4. Describe how the body physiologically reacts when hemolysis is present. 5. Discuss hematological and biochemical tests, used in the laboratory investigation of hemolysis. Copyright© 2018 Sysmex America, Inc. All rights reserved. 2 What is hemolysis? • Premature breakdown of red blood cells • Where can hemolysis occur? • Within the macrophages of the Mononuclear Phagocyte System (MPS) • Within the blood vessels 1 9/23/2018 What is the normal aging process of red blood cells? • Average life span 120 days • What is the MPS? • RBCs have no nucleus – cannot • Mononuclear cells with pronounced phagocytic ability that are distributed synthesize new cellular extensively in lymphoid and other components organs. • Old/damaged RBCS are removed by macrophages within the MPS, most notably the Spleen • A small percentage break down within the circulation – cellular fragments are engulfed by macrophages. Urobilinogen (urine) Process of normal RBC breakdown Macrophage RBC Protoporphyrin Globin Reabsorbed Iron Amino acids Bilirubin Amino acids Binds to transferrin Unconjugated bilirubin Transported to the bone Bilirubin General protein synthesis marrow for incorporation glucoronides into erythroblasts (hgb formation Stercobilinogen (feces) What causes hemolysis? • Some diseases and disease processes cause RBCs to breakdown prematurely • Normal response is for bone marrow to increase hematopoiesis • Causes of hemolysis can be broadly classified as being either intrinsic or extrinsic to the RBC • Intrinsic – occurs as a result of RBC defect • Most are hereditary • PNH is an exception – (acquired disorder) • Extrinsic – occurs as a result of ‘extracorpuscular’ or ‘environmental’ factors • patient’s own RBCs as well as any transfused RBCs will be affected as long as the causative factor remains in place 2 9/23/2018 Intrinsic causes of hemolysis RBC defects Hereditary conditions RBC membrane defects 1. Hereditary Spherocytosis (HS) 2. Hereditary Elliptocytosis 3. Hereditary Stomatocytosis Enzyme defects 1. Glucose-6-phosphate dehydrogenase deficiency (G6PD) 2. Pyruvate Kinase deficiency (PKD) Hemoglobin defects 1. Sickle cell disease (HbS) 2. Hemoglobin C 3. Thalassemia Extrinsic causes of hemolysis • Non-Immune • Immune • Prosethetic heart valves • Idiopathic • TTP • Autoimmune • HUS • Leukemia/Lymphoma • DIC • Drugs • Preeclampsia/HELLP • Infections syndrome • Alloimmune • Infections • Hemolytic transfusion rxn • Malaria • Hemolytic disease of the newborn • Clostridia Extrinsic causes of hemolysis – cont. • Chemical & physical agents • Certain drugs • Burns • Snake bites • Secondary to other disease • Liver and Renal disease • Mechanical stress • March hemoglobinuria 3 9/23/2018 Where does hemolysis take place? • Within the Mononuclear Phagocyte System (MPS) • This is referred to as ‘ Extravascular Hemolysis ’ • Directly in the circulation • This is referred to as ‘ Intravascular Hemolysis ’ • Generally speaking, intravascular hemolysis is more acute and more severe 10 Intravascular hemolysis • RBCs broken down directly in the circulatory system. • Free Hgb and RBC Enzymes (LDH) are released in circulation. • Hgb tetramer broken into dimers and immediately bound by Haptoglobin which is saturated and immediately cleared by the liver • A low Haptoglobin level is a hallmark of Intravascular hemolysis. • After Haptoglobin is saturated, excess free hgb is filtered in the kidneys and reabsorbed in the proximal tubules • Iron is recovered and converted into ferritin or hemosiderin • If rate of hemolysis is > renal tubule absorptive capacity, free hgb will be excreted in the urine (hemoglobinuria). Can be detected with urine strip. Extravascular hemolysis • Occurs when RBCs are phagocytosed by macrophages in the spleen, liver and bone marrow • No free hgb is released into circulation • No hemoglobinemia/hemoglobinuria with extravascular hemolysis alone • The breakdown of hgb within macrophages into its constituent components, heme and globin, occurs in the same manner as the normal aging process. 4 9/23/2018 The body’s reaction to hemolysis • Kidneys sensitive to changes in oxygenation of hgb. • Drop can occur due to a reduction in RBC mass (hemolysis or blood loss) • Release hormone Erythropoietin (EPO) • EPO is transported through plasma to BM where it accelerates erythropoiesis • EPO mechanism acts like a thermostat, increasing or decreasing erythropoiesis based on need • When hemolysis is taking place, the bone marrow will increase the production of RBCs relative to the amount of EPO produced • If rate of RBC destruction is greater than ability for BM to compensate the individual will become anemic. Detecting hemolysis in the lab • The approach in the dx of a hemolytic state involves: • Establishing that RBC destruction is accelerated • Establishing that erythropoiesis is increased • The cause of hemolysis must be determined as well. • If hemolytic anemia is suspected the following should be performed • Complete blood count • Reticulocyte count • Peripheral blood smear examination Tests reflecting increased RBC destruction Test Intravascular hemolysis Extravascular hemolysis 1. Haptoglobin Decreased/depleted Normal 2. Serum bilirubin Increased unconjugated bilirubin Increased unconjugated bilirubin 3. Urine test strip for hgb Positive Negative 4. Urine Hemosiderin Positive Negative 5. LDH Increased Normal 6. Hemopexin test Decreased/depleted Normal 7. Urine test strip for urobilinogen Positive Positive 8. Schumm’s test for methemalbumin Positive Negative 5 9/23/2018 Test reflecting increased RBC production • Reticulocyte Count • Reticulocytes remain in the BM for ~2 days before being released into the peripheral blood • # of Reticulocytes in the peripheral blood provides information about BM activity (erythropoiesis) • In the event of hemolysis, the BM will try to compensate by upregulating erythropoetic activity. • Reticulocyte population can be counted via manual or automated methods. Copyright© 2018 Sysmex America, Inc. All rights reserved. 16 Impact of artefactual hemolysis • The following practices can result in RBC lysis inside the collection tube ( in-vitro hemolysis) • Poor venipuncture technique • Exposure to excessively hot or cold temperatures (freezing) • Prolonged storage prior to analysis • It is important to be aware of this, as artefactual hemolysis may be very difficult to distinguish from intravascular hemolysis. In both cases on visual inspection, the plasma will have a reddish-brown color. Copyright© 2018 Sysmex America, Inc. All rights reserved. 17 Laboratory findings in artefactual hemolysis • The following findings suggest that in-vitro hemolysis has taken place: • A low RBC count and low HCT value with a normal HGB value. As a result, MCHC and MCH will appear raised. • No reticulocytosis even in the presence of RBC fragments. • Biochemical tests for intravascular hemolysis would be ‘negative’. Copyright© 2018 Sysmex America, Inc. All rights reserved. 18 6 9/23/2018 RBC Morphology in Hemolytic Anemias Copyright© 2018 Sysmex America, Inc. All rights reserved. 19 RBC morphology assoc. with hemolytic conditions RBC feature Description Underlying mechanism Disease states Basophilic Stippling Punctate basophilic Precipitated ribosomes Thalassemia and other inclusions anemias Copyright© 2018 Sysmex America, Inc. All rights reserved. 20 RBC morphology assoc. with hemolytic conditions-cont. RBC feature Description Underlying mechanism Disease states Bite Cells Smooth semicircle Heinz bodies G6PD and drug-induced removed from the margin oxidant hemolysis of the cell Copyright© 2018 Sysmex America, Inc. All rights reserved. 21 7 9/23/2018 RBC morphology assoc. with hemolytic conditions-cont. RBC feature Description Underlying mechanism Disease states Small, discrete basophilic Nuclear remnant Hemolytic anemias Howell-Jolly bodies dense inclusions; usually singular Copyright© 2018 Sysmex America, Inc. All rights reserved. 22 RBC morphology assoc. with hemolytic conditions-cont. RBC feature Description Underlying mechanism Disease states Microcytes Cells smaller than normal Abnormal hgb production Thalassemia (<7um) Copyright© 2018 Sysmex America, Inc. All rights reserved. 23 RBC morphology assoc. with hemolytic conditions-cont. RBC feature Description Underlying mechanism Disease states Polychromatophilia Grey or blue hue Ribosome material Reticulocytosis, premature frequently seen in release of RBC from BM reticulocytes Copyright© 2018 Sysmex America, Inc. All rights reserved. 24 8 9/23/2018 RBC morphology assoc. with hemolytic conditions-cont. RBC feature Description Underlying mechanism Disease states Schistocytes Distorted, fragemented Mechanical destruction Microangiopathic HA’s, cell, 2 or 3 pointed edges prosthetic valves, burns Copyright© 2018 Sysmex America, Inc. All rights reserved. 25 RBC morphology assoc. with hemolytic conditions-cont. RBC feature Description Underlying mechanism Disease states Stomatocytes Mouth- or cuplike Membrane defect with Hereditary stomatocytosis, deformity abnormal cation Immune-hemolytic anemia permeability Copyright© 2018 Sysmex America, Inc. All rights reserved. 26 RBC morphology assoc. with hemolytic conditions-cont. RBC feature Description Underlying mechanism Disease states Target-like appearance, Relative membrane Thalassemia,
Recommended publications
  • Hyperbilirubinemia

    Hyperbilirubinemia

    Porphyrins Porphyrins (Porphins) are cyclic tetrapyrol compounds formed by the linkage )). of four pyrrole rings through methenyl bridges (( HC In the reduced porphyrins (Porphyrinogens) the linkage of four pyrrole rings (tetrapyrol) through methylene bridges (( CH2 )) The characteristic property of porphyrins is the formation of complexes with the metal ion bound to nitrogen atoms of the pyrrole rings. e.g. Heme (iron porphyrin). Proteins which contain heme ((hemoproteins)) are widely distributed e.g. Hemoglobin, Myoglobin, Cytochromes, Catalase & Tryptophan pyrrolase. Natural porphyrins have substituent side chains on the eight hydrogen atoms numbered on the pyrrole rings. These side chains are: CH 1-Methyl-group (M)… (( 3 )) 2-Acetate-group (A)… (( CH2COOH )) 3-Propionate-group (P)… (( CH2CH2COOH )) 4-Vinyl-group (V)… (( CH CH2 )) Porphyrins with asymmetric arrangement of the side chains are classified as type III porphyrins while those with symmetric arrangement of the side chains are classified as type I porphyrins. Only types I & III are present in nature & type III series is more important because it includes heme. 1 Heme Biosynthesis Heme biosynthesis occurs through the following steps: 1-The starting reaction is the condensation between succinyl-CoA ((derived from citric acid cycle in the mitochondria)) & glycine, this reaction is a rate limiting reaction in the hepatic heme synthesis, it occurs in the mitochondria & is catalyzed by ALA synthase (Aminolevulinate synthase) enzyme in the presence of pyridoxal phosphate as a cofactor. The product of this reaction is α-amino-β-ketoadipate which is rapidly decarboxylated to form δ-aminolevulinate (ALA). 2-In the cytoplasm condensation reaction between two molecules of ALA is catalyzed by ALA dehydratase enzyme to form two molecules of water & one 2 molecule of porphobilinogen (PBG) which is a precursor of pyrrole.
  • The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: a Review

    The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: a Review

    Journal of Clinical Medicine Review The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review Felix Scholkmann 1,2,*, Tanja Restin 2, Marco Ferrari 3 and Valentina Quaresima 3 1 Biomedical Optics Research Laboratory, Department of Neonatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland 2 Newborn Research Zurich, Department of Neonatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland; [email protected] 3 Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy; [email protected] (M.F.); [email protected] (V.Q.) * Correspondence: [email protected]; Tel.: +41-4-4255-9326 Abstract: Following the outbreak of a novel coronavirus (SARS-CoV-2) associated with pneumonia in China (Corona Virus Disease 2019, COVID-19) at the end of 2019, the world is currently facing a global pandemic of infections with SARS-CoV-2 and cases of COVID-19. Since severely ill patients often show elevated methemoglobin (MetHb) and carboxyhemoglobin (COHb) concentrations in their blood as a marker of disease severity, we aimed to summarize the currently available published study results (case reports and cross-sectional studies) on MetHb and COHb concentrations in the blood of COVID-19 patients. To this end, a systematic literature research was performed. For the case of MetHb, seven publications were identified (five case reports and two cross-sectional studies), and for the case of COHb, three studies were found (two cross-sectional studies and one case report). The findings reported in the publications show that an increase in MetHb and COHb can happen in COVID-19 patients, especially in critically ill ones, and that MetHb and COHb can increase to dangerously high levels during the course of the disease in some patients.
  • Characterisation of Bilirubin Metabolic Pathway in Hepatic Mitochondria Siti Nur Fadzilah Muhsain M.Sc

    Characterisation of Bilirubin Metabolic Pathway in Hepatic Mitochondria Siti Nur Fadzilah Muhsain M.Sc

    Characterisation of Bilirubin Metabolic Pathway in Hepatic Mitochondria Siti Nur Fadzilah Muhsain M.Sc. (Medical Research) 2005 Universiti Sains Malaysia Postgrad. Dip. (Toxicology) 2003 University of Surrey B.Sc.(Biomed. Sc.) 2000 Universiti Putra Malaysia A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2014 School of Medicine ABSTRACT Bilirubin (BR), a toxic waste product of degraded haem, is a potent antioxidant at physiological concentrations. To achieve the maximum benefit of BR, its intracellular level needs to be carefully regulated. A system comprising of two enzymes, haem oxygenase-1 (HMOX1) and cytochrome P450 2A5 (CYP2A5) exists in the endoplasmic reticulum (ER), responsible for regulating BR homeostasis. This system is induced in response to oxidative stress. In this thesis, oxidative stress caused accumulation of these enzymes in mitochondria — major producers and targets of reactive oxygen species (ROS) — is demonstrated. To understand the significance of this intracellular targeting, properties of microsomal and mitochondrial BR metabolising enzymes were compared and the capacity of mitochondrial CYP2A5 to oxidise BR in response to oxidative stress is reported. Microsomes and mitochondrial fractions were isolated from liver homogenates of DBA/2J mice, administered with sub-toxic dose of pyrazole, an oxidant stressor. The purity of extracted organelles was determined by analysing the expressions and activities of their respective marker enzymes. HMOX1 and CYP2A5 were significantly increased in microsomes and even more so in mitochondria in response to pyrazole-induced oxidative stress. By contrast, the treatment did not increase either microsomes or mitochondrial Uridine-diphosphate-glucuronosyltransferase 1A1 (UGT1A1), the sole enzyme that catalyses BR elimination through glucuronidation.
  • Porphyrins & Bile Pigments

    Porphyrins & Bile Pigments

    Bio. 2. ASPU. Lectu.6. Prof. Dr. F. ALQuobaili Porphyrins & Bile Pigments • Biomedical Importance These topics are closely related, because heme is synthesized from porphyrins and iron, and the products of degradation of heme are the bile pigments and iron. Knowledge of the biochemistry of the porphyrins and of heme is basic to understanding the varied functions of hemoproteins in the body. The porphyrias are a group of diseases caused by abnormalities in the pathway of biosynthesis of the various porphyrins. A much more prevalent clinical condition is jaundice, due to elevation of bilirubin in the plasma, due to overproduction of bilirubin or to failure of its excretion and is seen in numerous diseases ranging from hemolytic anemias to viral hepatitis and to cancer of the pancreas. • Metalloporphyrins & Hemoproteins Are Important in Nature Porphyrins are cyclic compounds formed by the linkage of four pyrrole rings through methyne (==HC—) bridges. A characteristic property of the porphyrins is the formation of complexes with metal ions bound to the nitrogen atom of the pyrrole rings. Examples are the iron porphyrins such as heme of hemoglobin and the magnesium‐containing porphyrin chlorophyll, the photosynthetic pigment of plants. • Natural Porphyrins Have Substituent Side Chains on the Porphin Nucleus The porphyrins found in nature are compounds in which various side chains are substituted for the eight hydrogen atoms numbered in the porphyrin nucleus. As a simple means of showing these substitutions, Fischer proposed a shorthand formula in which the methyne bridges are omitted and a porphyrin with this type of asymmetric substitution is classified as a type III porphyrin.
  • Determination of Urinary Porphyrin by DEAE-Cellulose Chromatography and Visual Spectrophotometry

    Determination of Urinary Porphyrin by DEAE-Cellulose Chromatography and Visual Spectrophotometry

    A n n a l s o f C l i n i c a l a n d L a b o r a t o r y S c i e n c e , Vol. 4, No. 1 Copyright © 1974, Institute for Clinical Science Determination of Urinary Porphyrin by DEAE-Cellulose Chromatography and Visual Spectrophotometry MARTHA I. WALTERS, P h .D.* Ohio Valley Hospital, Steubenville, OH 43952 ABSTRACT A simple, reliable and rapid method for the isolation and determination of urinary porphyrins is described. Both uroporphyrin and coproporphyrin are quantitatively adsorbed by DEAE cellulose. Urobilinogen, urobilin, and bili­ rubin are removed with sodium acetate. The isolated porphyrins, eluted with 1 N HC1, are measured spectrophotometrically, and the excretion is related to that of creatinine. Porphyrin excretion was studied in normal adults and children, and in patients with disorders of porphyrin metabolism ( e.g., in lead poisoning, hemolytic anemia, hepatic disease and porphyria) in order to eval­ uate the method. The coefficient of variation of replicate analyses of a sample containing 200 ¡xg porphyrin per gm creatinine was 3.5 percent. The correlation coefficient between 83 duplicate analyses was 0.993. Introduction or adsorption onto an adsorbant followed Patients with porphyria show great in­ by elution. Methods combining extraction creases in the excretion of uroporphyrin, and adsorption have been the most com­ coproporphyrin and their precursors indi­ monly used,3’12 but procedures employing cating a primary abnormality of porphyrin ion-exchange chromatography,11’13 electro­ synthesis (figure 1). In addition to these phoresis,4’10 and thin-layer chromatogra­ disorders, there are a number of diseases phy15’16 also have been described.
  • Approach to Anemia

    Approach to Anemia

    APPROACH TO ANEMIA Mahsa Mohebtash, MD Medstar Union Memorial Hospital Definition of Anemia • Reduced red blood mass • RBC measurements: RBC mass, Hgb, Hct or RBC count • Hgb, Hct and RBC count typically decrease in parallel except in severe microcytosis (like thalassemia) Normal Range of Hgb/Hct • NL range: many different values: • 2 SD below mean: < Hgb13.5 or Hct 41 in men and Hgb 12 or Hct of 36 in women • WHO: Hgb: <13 in men, <12 in women • Revised WHO/NCI: Hgb <14 in men, <12 in women • Scrpps-Kaiser based on race and age: based on 5th percentiles of the population in question • African-Americans: Hgb 0.5-1 lower than Caucasians Approach to Anemia • Setting: • Acute vs chronic • Isolated vs combined with leukopenia/thrombocytopenia • Pathophysiologic approach • Morphologic approach Reticulocytes • Reticulocytes life span: 3 days in bone marrow and 1 day in peripheral blood • Mature RBC life span: 110-120 days • 1% of RBCs are removed from circulation each day • Reticulocyte production index (RPI): Reticulocytes (percent) x (HCT ÷ 45) x (1 ÷ RMT): • <2 low Pathophysiologic approach • Decreased RBC production • Reduced effective production of red cells: low retic production index • Destruction of red cell precursors in marrow (ineffective erythropoiesis) • Increased RBC destruction • Blood loss Reduced RBC precursors • Low retic production index • Lack of nutrients (B12, Fe) • Bone marrow disorder => reduced RBC precursors (aplastic anemia, pure RBC aplasia, marrow infiltration) • Bone marrow suppression (drugs, chemotherapy, radiation)
  • Hemoglobin Catabolism in Human Macrophages and Inflammation

    Hemoglobin Catabolism in Human Macrophages and Inflammation

    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2010 Hemoglobin catabolism in human macrophages and inflammation Kämpfer, Theresa Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-164025 Dissertation Published Version Originally published at: Kämpfer, Theresa. Hemoglobin catabolism in human macrophages and inflammation. 2010, University of Zurich, Faculty of Science. Hemoglobin Catabolism in Human Macrophages and Inflammation Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr.sc.nat.) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Theresa Kämpfer aus Deutschland Promotionskomitee Prof. Dr. Adriano Fontana (Vorsitz) Prof. Dr. Gabriele Schoedon PD Dr. Dominik Schaer Prof. Dr. Burkhard Becher Zürich, 2010 Preface 2 I. Preface This thesis was performed at the Inflammation Research Unit, Department of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland. It is an account of the results of projects supported by Fonds zur Föderung des Akademischen Nachwuchses (FAN) of the University of Zurich, and partially project No. 31-120658 of the Swiss National Science Foundation. The aim of this work was to study the hemoglobin induced catabolism in human macrophages and the resulting global and characteristic impact on the transcriptome and proteome in order to define a novel phenotype of hemoglobin clearing macrophages in wounded tissues and inflammation. The data is presented in form of manuscripts submitted or prepared for publication (chapters 2, 3, and 4). In chapter 1, an introduction in the biology of macrophages with emphasis on their role in hemoglobin clearance and catabolism, and an outline of the thesis are given.
  • 16Th March 2020 Blood Revised

    16Th March 2020 Blood Revised

    Blood is the fluid circulating in a closed system of blood vessels and the chambers of the heart It is the medium which transports substances from one part of the body to the other Blood is composed of Plasma Platelets Cells WBCs RBCs (Erythrocytes) Hemoglobin (Hb) is red , oxygen carrying pigment present exclusively in erythrocytes HEMOGLOBIN A conjugated protein containing Globin Protein part ( 4 polypeptide chains- ) 96% of the total Hb mass Varies from species to species( species specificity) Heme Non protein (prosthetic group) Red colour Iron containing tetrapyrrole porphyrin derivative 4% of the total Hb mass Reversibly binds Oxygen Structure of Heme An Iron –porphyrin (Protoporphrin IX) compound with tetrapyrrole structure Protoporphyrin IX consists of 4 pyrrole rings combined through — CH= bridges (methyne bridges) The methyne bridges are referred as α,β,γ, and δ. The 2 Hydrogen atoms in the –NH groups pyrrole rings (II & IV) are replaced by Ferrous( Fe++) . The four pyrrole rings present in the porphyrin molecule are designated as I,II,III & IV . Each of these four rings has 2 groups attached to them M = Methyl –CH3 V = Vinyl – CH=CH2 P = Propionyl - CH2 - CH2 - COOH . The Fe++ can form 2 additional bonds .One of these position is linked internally (5th linkage ) to nitrogen of imidazole ring of Histidine of the Globin polypeptide chains . Other position is available to bind Oxygen Heme is the most prevalent metalloporphyrin in humans Common prosthetic group in Hemoglobin — Transport of O2 in blood Myoglobin — Storage of O2 in muscles Cytochromes — Part of electron transport chain Catalase — Degradation of H2O2 Tryptophan pyrolase — Oxidation of Tryptophan Cytochrome P450 — Hydroxylation of Xenobiotics HEME SYNTHESIS Major sites Liver Erythrocyte producing cells of bone marrow Rate of heme synthesis in liver is highly variable & depends upon size of heme pool while it is relatively constant in in bone marrow is relatively constant Mature RBC lack mitochondria and are unable to synthesize heme.
  • PORPHYRIA by PROFESSOR CHARLES GRAY King's College Hospital Medical School, London

    PORPHYRIA by PROFESSOR CHARLES GRAY King's College Hospital Medical School, London

    i86 Postgrad Med J: first published as 10.1136/pgmj.32.366.186 on 1 April 1956. Downloaded from PORPHYRIA By PROFESSOR CHARLES GRAY King's College Hospital Medical School, London Three types of porphyria are recognized The involvement of the central nervous system clinically: (i) A congenital, or photo-sensitive, leads to irregularly distributed flaccid paralyses, form, (2) an acute intermittent form and (3) a sometimes involving only a single muscle group, chronic or mixed form. Although on clinical sometimes involving most of the striated muscle of grounds these differ greatly from one another so the body. The clinical picture is very varied, that they have been regarded as distinct diseases, it however, and the neurological features may be now seems possible that this is not so. They are limited to ptosis, a facial palsy, diplopia, disphonia usually regarded as uncommon diseases but it is or dysphasia. Many cases have been erroneously likely that as they become more widely known they diagnosed as hysteria, acute psychosis, polio- will more frequently be recognized. The por- myelitis or encephalitis. These neurological phyrias are characterized by an abnormal excretion manifestations are essentially those of a poly- of porphyrins or of porphyrin derivatives. Normal neuritis and histological studies reveal a patchy urine and faeces contain minute quantities of degeneration of peripheral nerves and anterior porphyrins and only small increases in the horn cells. When the bulbar centres are affected quantities' excreted occur in such conditions as there is early respiratory failure and rapid death.by copyright. pernicious anaemia, liver disease, lead poisoning, On the other hand, if recovery occurs it may be poliomyelitis and various forms of haemolytic remarkably complete even in the most serious anaemia.
  • A High Urinary Urobilinogen / Serum Total Bilirubin Ratio Reported in Abdominal Pain Patients Can Indicate Acute Hepatic Porphyria

    A High Urinary Urobilinogen / Serum Total Bilirubin Ratio Reported in Abdominal Pain Patients Can Indicate Acute Hepatic Porphyria

    A High Urinary Urobilinogen / Serum Total Bilirubin Ratio Reported in Abdominal Pain Patients Can Indicate Acute Hepatic Porphyria Chengyuan Song Shandong University Qilu Hospital Shaowei Sang Shandong University Qilu Hospital Yuan Liu ( [email protected] ) Shandong University Qilu Hospital https://orcid.org/0000-0003-4991-552X Research Keywords: acute hepatic porphyria, urinary urobilinogen, serum total bilirubin Posted Date: June 14th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-587707/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/10 Abstract Background: Due to its variable symptoms and nonspecic laboratory test results during routine examinations, acute hepatic porphyria (AHP) has always been a diagnostic dilemma for physicians. Misdiagnoses, missed diagnoses, and inappropriate treatments are very common. Correct diagnosis mainly depends on the detection of a high urinary porphobilinogen (PBG) level, which is not a routine test performed in the clinic and highly relies on the physician’s awareness of AHP. Therefore, identifying a more convenient indicator for use during routine examinations is required to improve the diagnosis of AHP. Results: In the present study, we retrospectively analyzed laboratory examinations in 12 AHP patients and 100 patients with abdominal pain of other causes as the control groups between 2015 and 2021. Compared with the control groups, AHP patients showed a signicantly higher urinary urobilinogen level during the urinalysis (P < 0.05). However, we showed that the higher urobilinogen level was caused by a false- positive result due to a higher level of urine PBG in the AHP patients. Hence, we used serum total bilirubin, an upstream substance of urinary urobilinogen synthesis, for calibration.
  • About Wales' Pathology Handbook

    About Wales' Pathology Handbook

    Aneurin Bevan University Health Board About Wales' Pathology Handbook Wales Pathology Handbook (WPH) is a knowledge service within the Welsh national information architecture. It provides national and local catalogues of requestable tests, rules and guidance for electronic requesting (via the Welsh Clinical Portal (WCP) and GP systems) and a web-based knowledge resource for all clinical staff. The introduction of the new national Laboratory Information Management System (LIMS) for Wales means that the operational WPH needs to be reviewed and updated to ensure that it is fit for purpose in the future environment. Page 1 of 697 Date Created - Monday, September 27, 2021 Aneurin Bevan University Health Board Departments Andrology Blood Sciences Cytology Histopathology Microbiology Mortuary Services Transfusion Page 2 of 697 Date Created - Monday, September 27, 2021 Aneurin Bevan University Health Board Andrology Department Information PLEASE NOTE: THE PATHOLOGY HANDBOOK INFORMATION BELOW IS ONLY VALID AT THE TIME OF ACCESS, PRINTED COPIES MUST NOT BE USED Andrology services available are: Semen analysis for fertility investigations. Semen analysis following a vasectomy. Retrograde Ejaculation Investigation. Andrology work is carried out within the Andrology Department, Pathology at Nevill Hall Hospital. Lead Andrologist: Mrs Karen Llewelyn (01873 733062). Deputy Lead: Mrs Ruth Lancaster (01873 733062). Department Manager: Mr Julian Bendle (01633 234502). Please Scroll or Page Down for additional information relating to telephone numbers, sample requesting and collection. ROUTINE OPENING TIMES Nevill Hall site: Andrology Service Monday to Friday: 9:00am - 5:00pm Semen samples for Fertility analysis, Vasectomy analysis or Retrograde Ejaculation Investigation are processed by appointment only. Any sample booked without an appointment will not be tested.

  • Circular of Information for the Use of Human Blood and Blood Components

    CIRCULAR OF INFORMATION FOR THE USE OF HUMAN BLOOD Y AND BLOOD COMPONENTS This Circular was prepared jointly by AABB, the AmericanP Red Cross, America’s Blood Centers, and the Armed Ser- vices Blood Program. The Food and Drug Administration recognizes this Circular of Information as an acceptable extension of container labels. CO OT N O Federal Law prohibits dispensing the blood and blood compo- nents describedD in this circular without a prescription. THIS DOCUMENT IS POSTED AT THE REQUEST OF FDA TO PROVIDE A PUBLIC RECORD OF THE CONTENT IN THE OCTOBER 2017 CIRCULAR OF INFORMATION. THIS DOCUMENT IS INTENDED AS A REFERENCE AND PROVIDES: Y • GENERAL INFORMATION ON WHOLE BLOOD AND BLOOD COMPONENTS • INSTRUCTIONS FOR USE • SIDE EFFECTS AND HAZARDS P THIS DOCUMENT DOES NOT SERVE AS AN EXTENSION OF LABELING REQUIRED BY FDA REGUALTIONS AT 21 CFR 606.122. REFER TO THE CIRCULAR OF INFORMATIONO WEB- PAGE AND THE DECEMBER 2O17 FDA GUIDANCE FOR IMPORTANT INFORMATION ON THE CIRCULAR. C T O N O D Table of Contents Notice to All Users . 1 General Information for Whole Blood and All Blood Components . 1 Donors . 1 Y Testing of Donor Blood . 2 Blood and Component Labeling . 3 Instructions for Use . 4 Side Effects and Hazards for Whole Blood and P All Blood Components . 5 Immunologic Complications, Immediate. 5 Immunologic Complications, Delayed. 7 Nonimmunologic Complications . 8 Fatal Transfusion Reactions. O. 11 Red Blood Cell Components . 11 Overview . 11 Components Available . 19 Plasma Components . 23 Overview . 23 Fresh Frozen Plasma . .C . 23 Plasma Frozen Within 24 Hours After Phlebotomy . 28 Components Available .